Taysha Gene Therapies Inc (TSHA)
$4.13 -2.13% Close Oct 30, 2026 Live
Taysha Gene Therapies stock today
Taysha Gene Therapies closed at $4.13 on October 30, 2026, down 2.13% on the day. Over the past year it returned -15.9% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $1.19 billion.
$4.00$6.00
NovJan 2026MarMayJulSep
| Period | TSHA | S&P 500 (SPY) |
|---|---|---|
| 1 month | -15.2% | -0.9% |
| 3 months | -29.7% | +2.1% |
| Year to date | -24.9% | +11.7% |
| 1 year | -15.9% | +12.4% |
| 3 years | +82.7% | +88.5% |
| 5 years | -73.6% | +76.0% |
Key statistics
- Market value
- $1.19B
- Price / sales
- 216.4
- 52-week range
- $3.51 to $6.98
- Next report
- Nov 4, 2026
About Taysha Gene Therapies
Develops gene therapy treatments for rare genetic neurological and neuromuscular diseases.
Sector: Health Care
More on Taysha Gene Therapies
- Financials: revenue, earnings and segmentsRevenue +17% in the year to Dec 2025
- Returns: what $1,000 became$1,000 five years ago is $264.07 today
No forecast, no recommendation. This page describes Taysha Gene Therapies Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.